Page last updated: 2024-09-03

candoxatrilat and vildagliptin

candoxatrilat has been researched along with vildagliptin in 1 studies

Compound Research Comparison

Studies
(candoxatrilat)
Trials
(candoxatrilat)
Recent Studies (post-2010)
(candoxatrilat)
Studies
(vildagliptin)
Trials
(vildagliptin)
Recent Studies (post-2010) (vildagliptin)
46101793186566

Protein Interaction Comparison

ProteinTaxonomycandoxatrilat (IC50)vildagliptin (IC50)
Dipeptidyl peptidase 9Bos taurus (cattle)0.68
Dipeptidyl peptidase IVPorphyromonas gingivalis1.3
Dipeptidyl peptidase 4Homo sapiens (human)0.1496
Dipeptidyl peptidase 4Mus musculus (house mouse)0.051
Prolyl endopeptidase FAPHomo sapiens (human)2.497
Dipeptidyl peptidase 8Homo sapiens (human)3.0627
Dipeptidyl peptidase 9Homo sapiens (human)0.4224
Dipeptidyl peptidase 2Homo sapiens (human)0.051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berellini, G; Lombardo, F; Springer, C; Waters, NJ1

Other Studies

1 other study(ies) available for candoxatrilat and vildagliptin

ArticleYear
In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set.
    Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14

    Topics: Computational Biology; Humans; Least-Squares Analysis; Linear Models; Nonlinear Dynamics; Pharmacokinetics; Principal Component Analysis

2009